Effect of lab timing on detection of toxicities in patients Undergoing 177Lu-dotatate treatment for neuroendocrine tumors
Meeker, Laura
2023

Files

Abstract

For patients receiving Lu-DOTATATE therapy (four cycles every 8 weeks) for treatment of neuroendocrine tumors: does timing of laboratory assessment between treatment cycles have an impact on proportion of patients that must continue therapy at a reduced dose? And/or the proportion of patients that must postpone a subsequent infusion, or proportion of patients that must discontinue the therapy?

Details

Title Effect of lab timing on detection of toxicities in patients Undergoing 177Lu-dotatate treatment for neuroendocrine tumors
Creator Meeker, Laura : Oregon Health and Science University
Contributor Mittra, Erik Mentor (Oregon Health and Science University)
Publisher Oregon Health and Science University
Date 2023
Subjects
Keywords
DOI https://doi.org/10.6083/c247ds915
Content Type Capstone
Degree Type M.D.
Academic Program Medicine (Undergraduate Medical Education)
School School of Medicine
Usage Statement
Record ID 10092
Record Created 2023-06-29
Record Appears in OHSU Works > Student Work > Academic Programs > School of Medicine Programs > Medicine (Undergraduate Medical Education)
OHSU Works > Student Work > Degrees > Medical Doctor (M.D.)
OHSU Works > Student Work > Scholarly Project Capstones
Organizations > Schools > School of Medicine
OHSU Works > Student Work > Capstones
All Records

PDF

Statistics

from
to
Export
Download Full History